×
About 5,370 results

ALLMedicine™ Dermatomyositis Center

Research & Reviews  1,769 results

Pain profile and opioid medication use in patients with idiopathic inflammatory myopath...
https://doi.org/10.1093/rheumatology/keac271
Rheumatology (Oxford, England); Bhashyam A, Lubinus M et. al.

May 18th, 2022 - Pain is commonly reported in people living with myositis. This study assesses the presence of pain in the subtypes of myositis as well frequency of opioid and non-opioid pain medication use. A survey was developed and distributed by Myositis Suppo...

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibod...
https://doi.org/10.1093/rheumatology/keac288
Rheumatology (Oxford, England); Selickaja S, Galindo-Feria AS et. al.

May 18th, 2022 - Anti-TIF1-gamma autoantibodies can be detected with immunoprecipitation (IP), line blot (LB), and enzyme-linked immunosorbent assay (ELISA). We compared assay performance in patients with dermatomyositis (DM) and the potential of these assays to d...

Adipose tissue distribution is associated with cardio-metabolic alterations in adult pa...
https://doi.org/10.1093/rheumatology/keac293
Rheumatology (Oxford, England); Marstein HS, Witczak BN et. al.

May 17th, 2022 - Primary aims were to compare adipose tissue distribution in adult patients with juvenile-onset dermatomyositis (JDM), with matched controls. Secondary aims were to explore how adipose tissue distribution is associated with cardio-metabolic status ...

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antib...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097056
BMC Pulmonary Medicine; Sato Y, Tanino Y et. al.

May 14th, 2022 - Inflammatory myositis, such as dermatomyositis, is sometimes complicated by cancer and is recognized as cancer-associated myositis. Although some autoimmune antibodies are considered to be involved in the development of myositis in cancer patients...

see more →

Guidelines  3 results

Treatment consensus for management of polymyositis and dermatomyositis among rheumatolo...
https://doi.org/10.1111/1346-8138.14604
The Journal of Dermatology; Kohsaka H, Mimori T et. al.

Dec 19th, 2018 - Although rheumatologists, neurologists and dermatologists see patients with polymyositis (PM) and dermatomyositis (DM), their management appears to vary depending on the physician's specialty. The aim of the present study was to establish the trea...

2016 American College of Rheumatology/European League Against Rheumatism Criteria for M...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517365
Annals of the Rheumatic Diseases; Rider LG, Aggarwal R et. al.

Apr 8th, 2017 - To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 definitions that used core set measures from either the International Myositis Assessment and Clinical Studies Group (IMACS) or the Paediatric Rheum...

2016 American College of Rheumatology/European League Against Rheumatism criteria for m...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496443
Annals of the Rheumatic Diseases; Aggarwal R, Rider LG et. al.

Apr 8th, 2017 - To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert surveys, logistic regression, and conjoint analysis were used to develop 287 definitions using core set measures. Myositis experts rated greater improvement ...

see more →

Drugs  197 results see all →

Clinicaltrials.gov  33 results

Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis
https://clinicaltrials.gov/ct2/show/NCT03267277

May 13th, 2022 - Calcinosis, a serious complication of dermatomyositis, involves deposition of calcium (carbonate apatite) in soft tissue, and can result in negative impacts on quality of life and physical function. To date, there are no known effective therapies ...

Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
https://clinicaltrials.gov/ct2/show/NCT04723303

Apr 20th, 2022 - This study will investigate Umbilical Cord Lining Stem Cells (ULSC) as an investigational medicinal product and its use in patients with polymyositis (PM) or dermatomyositis (DM) to see if a single intravenous (IV) infusion of allogeneic umbilical...

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
https://clinicaltrials.gov/ct2/show/NCT04033926

Mar 14th, 2022 - "This is a Phase 2 randomized, double-blind, placebo-controlled, crossover, multicenter study to evaluate the safety, tolerability, efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of treatment with KZR-616 in patients with active Polymyo...

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
https://clinicaltrials.gov/ct2/show/NCT03582800

Jan 10th, 2022 - Ectopic soft tissue calcifications or ossifications can complicate the course of numerous diseases; most of them are rare or very rare. Even if the clinical, radiological and pathological presentation of ectopic calcifications and ossifications ar...

Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)
https://clinicaltrials.gov/ct2/show/NCT02728752

Dec 23rd, 2021 - Prospective, Double-blind, Randomized, Placebo-Controlled Phase III Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis ("ProDERM study")

see more →

News  137 results

Lenabasum Improved Skin Symptoms in Dermatomyositis, but Future Is Uncertain
https://www.medscape.com/viewarticle/974012

May 13th, 2022 - An investigative synthetic cannabinoid receptor type 2 (CB2) agonist, lenabasum, was associated with greater improvements than placebo in patients with skin-predominant dermatomyositis — some of it statistically significant — in a phase 2 double-b...

Unique Dermatology Residency Track Focuses on Rural Placement of Graduates
https://www.medscape.com/viewarticle/973788

May 11th, 2022 - BOSTON – As a former active-duty cavalry officer in the U.S. Army who served a 15-month tour in Iraq in 2003, Adam C. Byrd, MD, isn't easily rattled. On any given day, as the only dermatologist in his hometown of Louisville, Miss., which has a pop...

Fast Five Quiz: Progressive Fibrosing Interstitial Lung Disease
https://www.medscape.com/viewarticle/969959

Apr 12th, 2022 - Interstitial lung diseases (ILDs) encompass a large and varied group of parenchymal lung disorders, including diseases of unknown cause, which are known as idiopathic interstitial pneumonias, as well as those associated with other diseases or envi...

Predicting Treatment Response in Inflammatory Muscle Disorders
https://www.medpagetoday.com/rheumatology/generalrheumatology/97219

Feb 16th, 2022 - Rheumatologists looking for clues to whether their patients with certain inflammatory myopathies will improve on immunosuppressive drugs may find them in a new study appearing in Arthritis Care & Research. Presence of dermatomyositis-specific auto...

Review Eyes Nail Unit Toxicities Secondary to Targeted Cancer Therapy
https://www.medscape.com/viewarticle/957155

Aug 24th, 2021 - Paronychia and periungual pyogenic granulomas are the most common nail unit toxicities related to targeted cancer therapies and immunotherapies, while damage to other nail unit anatomic areas can be wide-ranging. Those are key findings from an evi...

see more →

Patient Education  9 results see all →